Moderna
MRNA
196.48
+9.02
+4.81%
Moderna
US · MRNA
#406 by market cap
Listed 2018
196.48
+9.02
+4.81%
Live - 5344 symbols - heartbeat 252s ago
· 2026-10-08 07:40
Pre-market
194.92
-0.79%
After-hours
195.47
-0.51%
Overnight
195.45
-0.52%
- Market cap
- 78.44B
- P/E (TTM)i
- -24.62
- P/Bi
- 11.60
- EPSi
- -7.26
- Div yieldi
- 0.00%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on MRNA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 13 analysts
Hold
Avg price target
117.44 -40.2%
Price target rangecurrent 196.48
Low60.00
Avg117.44
High180.00
Buy 23%
Hold 62%
Sell 15%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | J.P. Morgan | -- | SELL | -- |
| 2026-09-18 | BofA Securities | -- | HOLD | 170.00 |
| 2026-09-11 | DBS | -- | HOLD | 150.00 |
| 2026-09-03 | Rothschild & Co Redburn | -- | SELL | 81.00 |
| 2026-08-27 | Argus Research | -- | BUY | 180.00 |
| 2026-08-25 | Wolfe Research | -- | HOLD | -- |
| 2026-08-21 | J.P. Morgan | -- | SELL | 77.00 |
| 2026-08-19 | William Blair | -- | BUY | -- |
| 2026-08-19 | BofA Securities | -- | HOLD | 170.00 |
| 2026-08-19 | Morgan Stanley | -- | HOLD | 89.00 |
| 2026-08-19 | Needham | -- | HOLD | -- |
| 2026-08-19 | Goldman Sachs | -- | HOLD | 120.00 |
| 2026-08-19 | RBC Capital | -- | HOLD | 130.00 |
| 2026-08-19 | J.P. Morgan | -- | SELL | 40.00 |
| 2026-08-06 | William Blair | -- | HOLD | -- |
| 2026-08-06 | Piper Sandler | -- | BUY | 77.00 |
| 2026-08-04 | J.P. Morgan | -- | SELL | 40.00 |
| 2026-08-03 | Piper Sandler | -- | BUY | 77.00 |
| 2026-08-03 | Citi | -- | HOLD | 60.00 |
| 2026-07-31 | William Blair | -- | HOLD | -- |
| 2026-07-31 | BofA Securities | -- | SELL | 40.00 |
| 2026-07-31 | Needham | -- | HOLD | -- |
| 2026-07-21 | Goldman Sachs | -- | HOLD | 67.00 |
| 2026-07-07 | BofA Securities | -- | SELL | 38.00 |
| 2026-06-27 | William Blair | -- | HOLD | -- |
Quant vs Street three independent views, side by side
StockVane factor grade
D
Momentum strategy signal
Strong Buy
Analyst consensus
Hold
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
4
■ Upgrades■ Downgrades
- 4 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Argus Research moved from Hold to Buy on 2026-08-27.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-27 | Argus Research | HOLD → BUY | 180.00 |
| 2026-08-25 | Wolfe Research | SELL → HOLD | -- |
| 2026-08-19 | BofA Securities | SELL → HOLD | 170.00 |
| 2026-08-19 | William Blair | HOLD → BUY | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-31 | -- | ±11.26% | -5.35% (in line) |
| 2026/Q1 | 2026-05-01 | -- | ±10.92% | -1.24% (in line) |
| 2025/Q4 | 2026-02-13 | -- | ±11.63% | +5.29% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±7.85% | +3.27% (in line) |
| 2025/Q2 | 2025-08-01 | -- | ±12.30% | -6.61% (in line) |
| 2025/Q1 | 2025-05-01 | -- | ±10.85% | -5.29% (in line) |
| 2024/Q4 | 2025-02-14 | -- | ±12.56% | +3.35% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±13.55% | -2.95% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±8.25% | -21.01% (beat) |
| 2024/Q1 | 2024-05-02 | -- | ±7.67% | +12.68% (beat) |
| 2023/Q4 | 2024-02-22 | -- | ±9.84% | +13.53% (beat) |
| 2023/Q3 | 2023-11-02 | -- | ±8.42% | -6.52% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:40:06 · For reference only, not investment advice and not tailored to your situation.